Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Crinetics Pharmaceuticals, Inc.

CRNX · — · CIK 0001658247 · Healthcare

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

47 Form 4 transaction lines observed in the same window
3 sales · 44 option, withholding, award, gift or other lines

Last qualifying purchase2023-06-08 · Vivaldi Coelho Rogerio · $110.3K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Vivaldi Coelho RogerioDirector
○▼○
Okey StephanieDirector
▼○○
Struthers Richard ScottPresident & CEO
○○○
Fust Matthew KDirector
○○
Deardorf CarenDirector
○○
Nichols WestonDirector
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-06-08 · Vivaldi Coelho Rogerio.

Recent Form 4 activity

0Purchases
18Sales
58Other Form 4 lines
40SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING3 sale line(s) · context only
OTHER44 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2023-06-08Vivaldi Coelho RogerioPurchase (P)Common Stock5,000USD 22.06USD 110,300SEC filing ↗
2022-04-18EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock157,515USD 22.22USD 3,499,983SEC filing ↗
2021-10-25EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock1,200,000USD 19.80USD 23,760,000SEC filing ↗
2021-04-08EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock304,136USD 16.44USD 4,999,996SEC filing ↗
2020-12-03Struthers Richard ScottPurchase (P)Common stock4,000USD 13.10USD 52,400SEC filing ↗
2020-12-02Struthers Richard ScottPurchase (P)Common stock1,000USD 12.60USD 12,600SEC filing ↗
2020-04-17EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock1,071,428USD 14.00USD 14,999,992SEC filing ↗

Form 4 evidence

76 transaction lines in the latest 365-day window; 372 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-01WIERENGA WENDELLD (D)Common Stock122,071USD 85.00USD 10,376,035SEC filing ↗
2026-09-01Vivaldi Coelho RogerioD (D)Common Stock19,225USD 85.00USD 1,634,125SEC filing ↗
2026-09-01Struthers Richard ScottD (D)Common Stock1,069,611USD 85.00USD 90,916,935SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-01WIERENGA WENDELLD (D)Common Stock122,071USD 85.00USD 10,376,035SEC filing ↗
2026-09-01Vivaldi Coelho RogerioD (D)Common Stock19,225USD 85.00USD 1,634,125SEC filing ↗
2026-09-01Struthers Richard ScottD (D)Common Stock1,069,611USD 85.00USD 90,916,935SEC filing ↗
2026-09-01Schilke TobinD (D)Common Stock79,427USD 85.00USD 6,751,295SEC filing ↗
2026-09-01Okey StephanieD (D)Common Stock12,325USD 85.00USD 1,047,625SEC filing ↗
2026-09-01Nichols WestonD (D)Common Stock22,225USD 85.00USD 1,889,125SEC filing ↗
2026-09-01Kalofonos IsabelD (D)Common Stock35,669USD 85.00USD 3,031,865SEC filing ↗
2026-09-01Fust Matthew KD (D)Common Stock28,761USD 85.00USD 2,444,685SEC filing ↗
2026-09-01Deardorf CarenD (D)Common Stock22,225USD 85.00USD 1,889,125SEC filing ↗
2026-09-01Betz Stephen F.D (D)Common Stock137,936USD 85.00USD 11,724,560SEC filing ↗
2026-09-01Bedrosian Camille LD (D)Common Stock22,225USD 85.00USD 1,889,125SEC filing ↗
2026-08-20Schilke TobinAward / grant (A)Common Stock471USD 0.00USD 0SEC filing ↗
2026-08-07Struthers Richard ScottOption exercise / conversion (M)Common Stock19,928USD 20.07USD 399,988SEC filing ↗
2026-07-02Vivaldi Coelho RogerioSale (S)Common Stock3,000USD 40.00USD 120,000SEC filing ↗
2026-06-18WIERENGA WENDELLAward / grant (A)Common Stock5,925USD 0.00USD 0SEC filing ↗
2026-06-18Vivaldi Coelho RogerioAward / grant (A)Common Stock5,925USD 0.00USD 0SEC filing ↗
2026-06-18Okey StephanieAward / grant (A)Common Stock5,925USD 0.00USD 0SEC filing ↗
2026-06-18Nichols WestonAward / grant (A)Common Stock5,925USD 0.00USD 0SEC filing ↗
2026-06-18Fust Matthew KAward / grant (A)Common Stock5,925USD 0.00USD 0SEC filing ↗
2026-06-18Deardorf CarenAward / grant (A)Common Stock5,925USD 0.00USD 0SEC filing ↗
2026-06-18Bedrosian Camille LAward / grant (A)Common Stock5,925USD 0.00USD 0SEC filing ↗
2026-06-17Okey StephanieSale (S)Common Stock6,900USD 35.67USD 246,143SEC filing ↗
2026-05-29Struthers Richard ScottGift (G)Common Stock413,300USD 0.00USD 0SEC filing ↗
2026-04-08Knight Jeff E.Sale (S)Common Stock85,163USD 40.10USD 3,415,036SEC filing ↗
2026-04-08Knight Jeff E.Option exercise / conversion (M)Common Stock78,434USD 22.42USD 1,758,818SEC filing ↗
2026-03-16Struthers Richard ScottSale (S)Common Stock21,981USD 37.37USD 821,513SEC filing ↗
2026-03-16Knight Jeff E.Sale (S)Common Stock9,911USD 37.37USD 370,411SEC filing ↗
2026-03-16Betz Stephen F.Sale (S)Common Stock10,612USD 37.37USD 396,610SEC filing ↗
2026-03-12Vivaldi Coelho RogerioSale (S)Common Stock5,000USD 36.15USD 180,761SEC filing ↗
2026-03-03Schilke TobinSale (S)Common Stock6,713USD 39.67USD 266,305SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCRNX
CIK0001658247
SectorHealthcare
Industry— Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
Exchange—

Data coverage

Local Form 4 history372 transaction lines from 2020-01-29 to 2026-09-01
7 P purchase lines · 171 S sale lines · 194 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.